Last €11.29 EUR
Change Today +0.99 / 9.56%
Volume 0.0
6DW On Other Exchanges
As of 2:27 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

d.western therapeutics insti (6DW) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/10/14 - €1,000
52 Week Low
02/5/14 - €3.63
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

d.western therapeutics insti (6DW) Related Businessweek News

No Related Businessweek News Found

d.western therapeutics insti (6DW) Details

D. Western Therapeutics Institute, Inc., a biotechnology company, is engaged in the discovery and development of drugs to serve patients worldwide. The company’s product pipeline includes K-134, an anti-platelet drug, which is in Phase IIb clinical trials; K-115, an anti-glaucoma drug that is in Phase III clinical trials; HMN-214, an anti-cancer drug, which has completed Phase-I clinical trials; and H-1129, an anti-glaucoma drug for the treatment of glaucoma. Its development projects comprise anti-glaucoma drugs; and ophthalmology and related area, central nervous system, cardiovascular system, and respiratory system drugs. D. Western Therapeutics Institute, Inc. was founded in 1999 and is headquartered in Nagoyashi, Japan.

13 Employees
Last Reported Date: 03/27/14
Founded in 1999

d.western therapeutics insti (6DW) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

d.western therapeutics insti (6DW) Key Developments

D.Western Therapeutics Institute, Inc. - Shareholder/Analyst Call

Company information session

D.Western Therapeutics Institute, Inc. to Report Q1, 2014 Results on May 14, 2014

D.Western Therapeutics Institute, Inc. announced that they will report Q1, 2014 results at 3:30 PM, Tokyo Standard Time on May 14, 2014

D.Western Therapeutics Institute, Inc., Annual General Meeting, Mar 27, 2014

D.Western Therapeutics Institute, Inc., Annual General Meeting, Mar 27, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6DW:GR €11.29 EUR +0.99

6DW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 6DW.
View Industry Companies

Industry Analysis


Industry Average

Valuation 6DW Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,268.3x
Price/Book 17.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,196.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact D.WESTERN THERAPEUTICS INSTI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at